- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostate Biopsy in South Africa
Total 560 results
-
RhoVac APSActive, not recruitingProstate Cancer RecurrentSweden, United States, Finland, United Kingdom, Belgium, Germany, Denmark
-
Inovio PharmaceuticalsCompletedProstate CancerUnited States
-
Sumitomo Pharma Switzerland GmbHActive, not recruitingMetastatic Castration-Resistant Prostate Cancer | Metastatic Castration-Sensitive Prostate Cancer | Non-Metastatic Castration-Resistant Prostate CancerUnited States
-
Medi-Tate Ltd.CompletedBenign Prostate HyperplasiaUnited States, Canada
-
VA Office of Research and DevelopmentRecruitingMetastatic Prostate CancerUnited States
-
GlaxoSmithKlineCompletedNeoplasms, ProstateUnited States, Australia, France, Germany, Spain, Bulgaria, Estonia, Italy, Poland, Netherlands, Belgium, United Kingdom, Canada, Denmark, Ukraine, Finland, Latvia, Russian Federation, Greece, Slovenia, Brazil, Mexico, Slovakia, Japan, Puerto... and more
-
DendreonTerminatedCastration-Resistant Prostate CancerUnited States
-
US Oncology ResearchEli Lilly and Company; Oregon Health and Science UniversityCompletedAndrogen-independent Prostate CancerUnited States
-
Christopher Sweeney, MBBSEli Lilly and Company; Walther Cancer InstituteCompletedProstate CancerUnited States
-
Trans Tasman Radiation Oncology GroupAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Urological...Active, not recruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Constellation PharmaceuticalsActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States, Canada
-
GP-PharmTerminatedProstate CancerUnited States
-
University of MiamiJay L. Friedland MD Prostate Cancer Research FundRecruitingProstate CancerUnited States, Australia, Italy
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate CancerUnited States, Canada
-
AmgenTerminatedMetastatic Castration-resistant Prostate CancerUnited States, Sweden, Spain, United Kingdom, Australia, Denmark
-
DendreonCompletedProstatic Neoplasms | Advanced Prostate CancerUnited States
-
Duke UniversityCompleted
-
Beth Israel Deaconess Medical CenterBristol-Myers Squibb; Dana-Farber Cancer InstituteActive, not recruitingProstate CancerUnited States
-
University of Colorado, DenverBoston Scientific CorporationTerminated
-
BayerOrion Corporation, Orion PharmaCompletedProstate Cancer Non-Metastatic | Castration-ResistantBelgium, France, Poland, Spain, Canada, United States, Estonia, Portugal, Taiwan, Japan, Russian Federation, Finland, Germany, Austria, Czechia, Hungary, Australia, Brazil, South Africa, Latvia, Italy, United Kingdom, Turkey, Serbia, Ro... and more
-
Myriad Genetic Laboratories, Inc.Carolina Urologic Research CenterCompleted
-
Mayo ClinicNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
GenesisCare USACompletedProstate AdenocarcinomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Centocor Research & Development, Inc.CompletedProstate CancerUnited States, United Kingdom, Belgium, Russian Federation
-
Bristol-Myers SquibbCompleted
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostatic Adenocarcinoma | Castration Levels of TestosteroneUnited States, Switzerland, Mexico, Chile, Colombia
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
AstraZenecaBayerRecruitingMetastatic Prostate CancerItaly, United Kingdom, Australia, United States
-
Arvinas Androgen Receptor, Inc.Active, not recruitingProstate Cancer MetastaticCanada, United States, France, United Kingdom
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Terminated
-
Orion Corporation, Orion PharmaCompletedProstate CancerUnited States, United Kingdom, Finland, France, Estonia, Czech Republic
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Astellas Pharma US, Inc.; Medivation, Inc.; Biologics...Active, not recruitingRecurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States, Canada, Puerto Rico
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingStage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | Stage I Prostate AdenocarcinomaUnited States, Canada, Puerto Rico
-
Clarity Pharmaceuticals LtdCompletedBiochemical Recurrence of Malignant Neoplasm of ProstateUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingHealthy | Prostate Cancer | Conditions Influencing Health StatusUnited States
-
MDx HealthTerminatedProstate CancerUnited States
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstatic Neoplasms | Hormone-Refractory Prostate CancerUnited States, Ireland, Australia, France, United Kingdom, Belgium, Germany, Netherlands, Poland, Spain
-
EDAP TMS S.A.UnknownProstate CancerUnited States, Canada
-
Laekna LimitedActive, not recruitingMetastatic Castration-resistant Prostate CancerUnited States, Korea, Republic of
-
Telix Pharmaceuticals (Innovations) Pty LimitedActive, not recruiting
-
Invitae CorporationCompleted
-
BioProtectCompletedProstate CancerUnited States, Israel, United Kingdom, Netherlands, Poland, Portugal
-
Ascenta TherapeuticsCompletedProstate CancerUnited States
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
AstraZenecaCompletedProstate CancerSweden, United States, Brazil, France, Peru, Spain, United Kingdom, Germany, Poland, Romania, Finland, Canada, Argentina, Australia, South Africa, Czech Republic, India, Netherlands, Italy, Switzerland, Korea, Republic of, Hungary, ... and more
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
Watson PharmaceuticalsCompletedProstate CancerUnited States